Corcept Therapeutics | Les Charges D'Exploitation



Operating Expenses Changement Date
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Alaunos Therapeutics USD 759K 391K 2024-12
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Ardelyx USD 108M 12M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
J&J USD 8.26B 10.37B 2025-03
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Pacira USD 162.55M 145.55M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12



Corcept Therapeutics Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.